The CARDIA Study: Statement from Dr. Claude Lenfant, director, National Heart, Lung, and Blood Institute

October 25, 1999

Note to reporters/editors:

The October 27, 1999, issue of the Journal of the American Medical Association (JAMA) spotlights the health risks of obesity, a major risk factor for heart disease. About 97 million American adults --55 percent of the population-- are now overweight or obese.

The JAMA issue includes three articles on research supported by the National Heart, Lung, and Blood Institute (NHLBI):

"Dietary Fiber, Weight Gain, and Cardiovascular Disease Risk Factors in Young Adults." This report examines the association of fiber consumption to insulin levels and the risk of cardiovascular disease (CVD). The researchers reviewed data from the multicenter NHLBI Coronary Artery Risk Development in Young Adults (CARDIA) Study. The attached statement describes the study of nearly 3,000 black and white young adults in more detail. The authors conclude that high-fiber diets may protect against obesity and CVD by lowering insulin levels. Catherine Loria, Ph.D., Epidemiologist, NHLBI, is available for comment on this study.

"Effects of Intermittent Exercise and Use of Home Exercise Equipment on Adherence, Weight Loss, and Fitness in Overweight Women." The researchers from Brown University and the University of Pittsburgh conducted an 18-month trial with overweight women. They found that, contrary to expectation, advice to exercise in short bouts rather than long bouts did not increase sustained adherence or long-term weight loss. However, the provision of home exercise equipment improved weight loss for those advised to exercise in short bouts compared with those advised to exercise in short bouts but were not provided equipment. Eva Obarzanek, Ph.D., Research Nutritionist, NHLBI, is available for comment on this study.

"Reducing Children's Television Viewing to Prevent Obesity." Dr. Thomas N. Robinson of Stanford University gives results of a trial that involved about 190 elementary school children. Children who received an 18-lesson, 6-month curriculum reduced their body mass index and their TV, videotape, and video game use. They also ate fewer meals in front of the TV. Elaine Stone, Ph.D., Health Scientist Administrator, NHLBI, is available for comment on this study.

Statement from Dr. Claude Lenfant, director, National Heart, Lung, and Blood Institute

High fiber diets may protect against obesity and cardiovascular disease (CVD) in healthy young adults by lowering insulin levels. This is one of the findings of an analysis of participants in the CARDIA Study (Coronary Artery Risk Development in Young Adults), sponsored by the National Heart, Lung, and Blood Institute (NHLBI). CARDIA is a long-term study examining the evolution of CVD risk factors in young adults. The new analysis indicates that fiber consumption is independently and inversely associated with insulin levels, weight gain and other CVD risk factors among healthy, young black and white adults. A report of this analysis, "Dietary Fiber, Weight Gain, and Cardiovascular Disease Risk Factors in Young Adults," appears in the October 27, 1999 edition of the Journal of the American Medical Association (JAMA).

The CARDIA Study, a multi-center, population-based study, is following young black and white adults in four US areas: Birmingham, AL, Chicago, IL, Minneapolis, MN, and Oakland, CA. The new analysis looked at 2,909 of the CARDIA participants over the 10 years between 1985-1986 to 1995-1996. Its purpose was to examine the role of fiber compared to fat and other major dietary components in the development of hyperinsulinemia (an abnormally high level of insulin in the blood), obesity and other CVD risk factors (e.g. hypertension, high blood cholesterol). Insulin resistance and hyperinsulinemia are associated with many of these risk factors.

The health benefits of dietary fiber have been the subject of research interest for some time. Findings from this new study support the positive effects of diets high in fiber. The authors discuss how fiber may affect the risk of CVD. They note that dietary fiber slows the rate of nutrient absorption following a meal, and may reduce insulin secretion. This study's findings need to be confirmed in long-term interventional studies which more fully examine the relationship between dietary fiber, insulin levels, and CVD risk factors.
-end-
For more information on CVD risk factors and heart health, visit the NHLBI Web site at www.nhlbi.nih.gov.

To arrange an interview with any of the NHLBI spokespersons listed, contact the NHLBI Communications Office at 301-496-4236.

NIH/National Heart, Lung and Blood Institute

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.